We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





Sysmex Middle East Presents Smart Lab Technologies at WHX Labs Dubai

By LabMedica International staff writers
Posted on 10 Feb 2026

Sysmex Middle East (Dubai, UAE) is participating in WHX Labs Dubai 2026 as the event’s Smart Lab Partner, showcasing its latest innovations and technologies across a wide range of clinical laboratory disciplines, alongside an educational workshop program. More...

At the company’s stand, key highlights include the UN-Series, a modular urinalysis solution that enables laboratories to automate the urinalysis work area according to their specific workflow requirements. With mix-and-match components, the system can be configured as a fully integrated, scalable solution that supports both current operations and future growth, offering a precise fit and long-term investment security.

Sysmex is also presenting its HISCL series of fully automated, random-access, high-sensitivity immunoassay analyzers designed to deliver rapid and precise clinical diagnostics. The company is emphasizing specialized applications such as liver disease and dementia, highlighting how highly sensitive platforms like the HISCL immunoassay analyzer enable blood-based measurement of Alzheimer’s disease biomarkers, including the β-amyloid 1-42/1-40 ratio.

In hemostasis, the CN-Series, including models such as the CN-3500 and CN-6500, is being highlighted, offering powerful productivity, analytical precision, and operational efficiency based on the “four powers” concept. In hematology, the XR-Series flagship portfolio is on display, providing flexible solutions ranging from standalone analyzers to fully automated systems that can be tailored to varying levels of workflow automation, diagnostic support, and service integration.

Additional exhibits include the company’s modular flow cytometry solutions, encompassing workflow management, automated sample preparation, and a comprehensive range of high-quality antibody reagents.

In parallel with its product showcase, Sysmex is hosting a workshop titled “Smartly linked haemato-oncology: Excellence in every drop” on February 12. The three-part educational session, led by an expert panel, will explore the intersection of laboratory innovation and health system transformation in the diagnosis and management of hematological malignancies.

Related Links:
Sysmex Middle East


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The addition of Biocare’s complementary IHC antibody, reagent and instrument portfolio enhances Agilent’s immunohistochemistry offering (Photo courtesy of Biocare Medical)

Agilent Technologies Acquires Pathology Diagnostics Company Biocare Medical

Agilent Technologies (Santa Clara, CA, USA) has entered into a definitive agreement to acquire Biocare Medical (Pacheco, CA, USA), expanding its pathology portfolio through the addition of highly complementary... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.